HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lambert-Eaton syndrome antibodies target multiple subunits of voltage-gated Ca2+ channels.

AbstractINTRODUCTION:
Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune presynaptic neuromuscular disorder. Autoantibodies against subunits of voltage-gated calcium channels (VGCCs) associated with acetylcholine release are thought to cause LEMS.
METHODS:
HEK293 cells expressing specific individual recombinant subunits of α(1A), α(1B), α(1C), and α(1E); β(3); and α(2)δ of human neuronal VGCCs were exposed to antibodies from 3 LEMS patients, 1 patient with small-cell lung carcinoma, and 1 with myasthenia gravis.
RESULTS:
All LEMS patient antibodies bound to cells containing any of the α(1) or β(3) subunits alone or combined with α(2)δ subunits, but not α(2)δ alone. Autoantibodies from the patient with small-cell lung carcinoma but not the myasthenia gravis patient targeted the same VGCC subunits.
CONCLUSIONS:
Autoantibodies from LEMS patients bind directly to multiple VGCC α(1) subunits as well as the β(3) subunit. Thus, multiple components of the presynaptic VGCC complex are prospective targets for antibodies in LEMS.
AuthorsRavindra K Hajela, Kristin M Huntoon, William D Atchison
JournalMuscle & nerve (Muscle Nerve) Vol. 51 Issue 2 Pg. 176-84 (Feb 2015) ISSN: 1097-4598 [Electronic] United States
PMID24862203 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2014 Wiley Periodicals, Inc.
Chemical References
  • Autoantibodies
  • Calcium Channels
  • Protein Subunits
  • Green Fluorescent Proteins
Topics
  • Autoantibodies (immunology)
  • Calcium Channels (genetics, immunology, metabolism)
  • Carcinoma, Small Cell (blood, immunology)
  • Green Fluorescent Proteins (genetics, metabolism)
  • HEK293 Cells
  • Humans
  • Lambert-Eaton Myasthenic Syndrome (blood, immunology)
  • Protein Subunits (genetics, metabolism)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: